Challenges, Progress and Promises of Impurities Annotation for LCMSIT- TOF

Author:

Özcan Saniye1,Levent Serkan1,Can Nafiz Öncü1

Affiliation:

1. Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu University, 26470, Eskisehir,Turkey

Abstract

: Analysis of pharmaceutical products, as well as their active and inactive ingredients, and identification and characterization of potential impurities originating from raw materials and manufacturing processes is of importance in the field, especially for further assessment of potential positive or negative effects on the human body. In addition to expected therapeutic effects, unfortunately, some unwanted or adverse effects were encountered in the past, resulting in dramatic cases sometimes. These challenges have been overcome with the use of sophisticated and high-end analytical techniques today by focusing on developing more efficient, more accurate, more accessible, and faster determination techniques. : One of the powerful techniques utilized under the given aim, especially for qualitative purposes, is the Time of Flight (TOF) based Mass Spectrometry (MS). Among the TOF-MS instruments, liquid chromatography- mass spectrometry-ion trap-time of flight (LCMS-IT-TOF) has a unique MSn capability, which is a versatile tool in exact mass prediction and structure elucidation. In this review, LCMS-ITTOF has been considered taking all aspects to account for its use in qualitative impurity profiling, and a retrospective view on previous studies was presented in an analytical manner.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science,Molecular Medicine,Biochemistry,Biophysics

Reference54 articles.

1. Holm R.; Elder D.P.; Analytical advances in pharmaceutical impurity profiling. Eur J Pharm Sci 2016,87,118-135

2. Guideline I.H.T.; In Impurities in new drug substances Q3A (R2 Proceedings of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland 2006

3. Guideline I. H. T.; Impurities in new drug products. Q3B (R2), current step 2006,,1-5

4. Guideline I.H.T.; Impurities: Guideline for residual solvents Q3C (R5). Curr Sep 2005,4,1-25

5. Guideline I. H.; Guideline for elemental impurities Q3D (R1), 2018

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3